Privately held Dyno Therapeutics Inc. has added another notch to its adeno-associated virus (AAV) vectors development ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

US artificial intelligence (AI) to gene therapy focussed biotech Dyno Therapeutics today announced its second research ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

But a session of E-tuning and another on an actual dyno was hugely beneficial to my humble Civic. Now, I’d tell anyone ...

Immediately upon throttle application, the dyno records almost 300 horsepower at zero miles per hour, and power peaks at 368 hp at around 55 mph (we imagine the "386HP" quoted on the video title ...

R&T's dyno runs sussed power numbers at the wheel of 223 hp and 245 lb-ft for the WRX, 247 hp and 243 lb-ft for the STI, then went on to demonstrate in numbers what everyone knew: that the WRX ...